Four-factor prothrombin complex concentrate for the reversal of factor Xa inhibitors for traumatic intracranial hemorrhage

The objective of this study was to determine the effectiveness and safety of four-factor prothrombin complex concentrate (4F-PCC) for the reversal of factor Xa inhibitors in patients with traumatic intracranial hemorrhage (ICH).

Source: The American Journal of Emergency Medicine - January 9, 2019 Category: Emergency Medicine Authors: Daniel Dybdahl, Grant Walliser, M. Chance Spalding, Michelle Pershing, Michelle Kincaid Source Type: research